GARS1 and KARS1 display androgen-dependent transcriptional initiation in several hormone-responsive cells, such as prostate cancer cells (Fig. 2c)19; thus, transcription of GARS1 and KARS1 is initiated in cancers with increases in AREs. Here, KARS1 is linked to prostate carcinoma.